Unknown

Dataset Information

0

A Tailorable In-Situ Light-Activated Biodegradable Vascular Scaffold.


ABSTRACT: Biodegradable vascular scaffolds (BVS) are novel treatments for obstructive atherosclerotic cardiovascular disease that have been developed to overcome the limitations of traditional metallic drug-eluting stents (DES). The mechanical properties of bioabsorbable polymers used for the production of novel BVS are a key consideration for the clinical translation of this emerging technology. Herein, we describe the engineering of an in situ light-activated vascular scaffold (ILVS) comprised of a biodegradable citric acid-based elastomeric polymer, referred to as methacrylated poly-diol citrate (mPDC), and a diazeniumdiolate chitosan nitric oxide donor (chitoNO). In vitro studies demonstrate that the mechanical properties of the ILVS can be tailored to meet or exceed those of commercially available self-expanding bare metal stents (BMS). The radial compression strength of the ILVS is higher than that of a BMS despite undergoing degradation at physiologic conditions for 7 months. ILVS containing chitoNO provides sustained supraphysiologic levels of NO release. Lastly, ILVS were successfully cast in porcine arteries ex vivo using a custom designed triple balloon catheter, demonstrating translational potential. In conclusion, these data demonstrate the ability of an ILVS to provide tunable mechanical properties and drug-delivery capabilities for the vasculature, and thereby support mPDC as a promising material for the development of novel BVS platforms.

SUBMITTER: Albaghdadi MS 

PROVIDER: S-EPMC5860681 | biostudies-literature | 2017 Apr

REPOSITORIES: biostudies-literature

altmetric image

Publications

A Tailorable In-Situ Light-Activated Biodegradable Vascular Scaffold.

Albaghdadi Mazen S MS   Yang Jian J   Brown Jessica H JH   Mansukhani Neel A NA   Ameer Guillermo A GA   Kibbe Melina R MR  

Advanced materials technologies 20170220 4


Biodegradable vascular scaffolds (BVS) are novel treatments for obstructive atherosclerotic cardiovascular disease that have been developed to overcome the limitations of traditional metallic drug-eluting stents (DES). The mechanical properties of bioabsorbable polymers used for the production of novel BVS are a key consideration for the clinical translation of this emerging technology. Herein, we describe the engineering of an <i>in situ</i> light-activated vascular scaffold (ILVS) comprised of  ...[more]

Similar Datasets

| S-EPMC3899884 | biostudies-literature
| S-EPMC10634235 | biostudies-literature
| S-EPMC4749136 | biostudies-literature
| S-EPMC2512263 | biostudies-literature
| S-EPMC10567580 | biostudies-literature
| S-EPMC4380102 | biostudies-other
| S-EPMC6536443 | biostudies-literature
| S-EPMC10703347 | biostudies-literature
| S-EPMC2748110 | biostudies-literature
| S-EPMC7780475 | biostudies-literature